Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial - Wikidata - wikimedia - TriplyDB

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

http://www.wikidata.org/entity/Q28351795

about

Common problems in the management of hypertriglyceridemia.Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy Dysfunctional high-density lipoprotein Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes Comparative account of serum lipids, lipoproteins and apolipoprotein-B in patients of coronary artery disease.Façons d’identifier et de prendre en charge la dyslipidémie athérogène: Une conséquence métabolique de l’obésité et du diabète.

P2860

Q34288485-D24A99E6-723F-4EDB-8153-8E5AB9BAE022 Q34417470-CA8C7140-57A3-4925-8F40-DD942AA09F7F Q34727869-43708E01-F44E-4EF6-B1E3-1CCC2026F8DA Q37308578-F7867F69-5318-43F9-A020-B410B28193F8 Q42005333-5ED5BF93-BD59-49F6-8665-93D5CF576CFA Q46488015-2E4C6417-436A-437F-B584-7790BE1932A8

P2860

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

http://www.wikidata.org/entity/Q28351795

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

@ast

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

@en

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

@nl

type

label

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

@ast

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

@en

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

@nl

prefLabel

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

@ast

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

@en

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

@nl

P1433

Q28351795-A0254800-5F5E-48E0-8C62-79E060774209

P1476

Q28351795-4070999D-17E8-4198-876F-086C77504858

P2093

Q28351795-228460C0-2544-4A34-A0D3-8731A44559A1

Q28351795-726F0588-3053-4616-9E5A-86D390275A01

Q28351795-ADEEAFBB-B905-4F4C-961A-74D1F1CC5D88

P2860

Q28351795-036282FC-A6A2-4C81-B795-2E61E84DB7AF

Q28351795-113484A5-A3B6-4022-A3E9-34835EDFCF85

Q28351795-149C440F-A671-45C0-B199-E203176D855C

Q28351795-1A74756A-BB65-4614-B6F3-5AE07A1C7000

Q28351795-3E8F94C5-B5A3-4A43-A889-98974F9EAE79

Q28351795-4E4BA31B-CF93-4659-A1A4-3BD11ECC9BBF

Q28351795-5292575C-C64A-4F0A-A6BA-B0CF5A2C4328

Q28351795-55B419E1-82B7-4D1C-B9F9-A482FBFCEC1D

Q28351795-5C62946B-3237-44EC-AB4F-3753C9D3AE01

Q28351795-5C9652E3-1E0C-4FB9-8648-1FF60740606C

P304

Q28351795-7D75CBDB-841C-487A-8C19-751083251212

P31

Q28351795-73621DE3-7EFD-455E-99E7-39D11EAB6DF1

P407

Q28351795-1172DE86-6BB5-40CE-9732-6639295FB456

P433

Q28351795-91945AFF-4B38-4FF6-B118-6F4C2F41351A

P478

Q28351795-D622F804-1067-4035-8AAB-B6AC9519C366

P577

Q28351795-F3CCD5E2-CBF2-4D13-8852-A89C64F618D9

P698

Q28351795-4E50D581-78CC-4B39-962B-BEF03B034521

P921

Q28351795-672132BC-9B5C-487E-9137-03A2DB5648D2

P932

Q28351795-715D3B2F-EF68-4A84-A84E-6EA603EBE3A3

P1433

Canadian Medical Association Journal

P1476

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial

@en

P2093

A D Sniderman

http://www.w3.org/2001/XMLSchema#string

J Bergeron

http://www.w3.org/2001/XMLSchema#string

J Frohlich

http://www.w3.org/2001/XMLSchema#string

P2860

A receptor-mediated pathway for cholesterol homeostasis

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

The role of the cardiovascular specialist in the prevention of cardiovascular diseases - executive summary.

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.

The adipocyte, fatty acid trapping, and atherogenesis.

Low density lipoprotein subfractions and [Ca2+]i in vascular smooth muscle cells.

Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects.

Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits. Differences in intimal clearance explained by size differences.

P304

44-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11209748

http://www.w3.org/2001/XMLSchema#string

P921

P932

80634

http://www.w3.org/2001/XMLSchema#string